Delivery Order SPE2DE24D0013-SPE2D625F9GS8

The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. This award represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert diagnostic systems and associated testing capabilities for infectious disease detection across federal healthcare networks.

This delivery order likely draws from one of Cepheid's two substantial federal Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, including the $32.8 million IDV with VA's Veterans Integrated Service Network 6, which supports molecular diagnostic testing through September 30, 2030. Cepheid is an established federal contractor specializing in advanced molecular diagnostic technologies and has consistently delivered PCR-based testing solutions to multiple federal agencies including the VA, Indian Health Service, and Defense Health Agency. The modest award value reflects either a specific, limited quantity order or a strategic replenishment of diagnostic reagents needed for near-term operational requirements within the Defense Department's medical supply chain.